Falk Steffen

1.2k total citations
42 papers, 555 citations indexed

About

Falk Steffen is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Falk Steffen has authored 42 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pathology and Forensic Medicine, 17 papers in Neurology and 11 papers in Oncology. Recurrent topics in Falk Steffen's work include Multiple Sclerosis Research Studies (25 papers), Polyomavirus and related diseases (7 papers) and Skin and Cellular Biology Research (6 papers). Falk Steffen is often cited by papers focused on Multiple Sclerosis Research Studies (25 papers), Polyomavirus and related diseases (7 papers) and Skin and Cellular Biology Research (6 papers). Falk Steffen collaborates with scholars based in Germany, Israel and Netherlands. Falk Steffen's co-authors include Stefan Bittner, Frauke Zipp, Timo Uphaus, Muthuraman Muthuraman, Klaus Gröschel, Sinah Engel, Sonja Gröschel, Rolf Wachter, Katrin Wasser and Mark Weber-Krüger and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Stroke.

In The Last Decade

Falk Steffen

38 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Falk Steffen Germany 13 255 187 97 78 67 42 555
Timo Uphaus Germany 18 308 1.2× 218 1.2× 190 2.0× 92 1.2× 113 1.7× 53 952
Benjamin Berger Germany 17 180 0.7× 345 1.8× 161 1.7× 66 0.8× 74 1.1× 54 725
Jonas Graf Germany 17 294 1.2× 209 1.1× 141 1.5× 71 0.9× 92 1.4× 41 775
Arianna Sartori Italy 14 194 0.8× 291 1.6× 75 0.8× 44 0.6× 69 1.0× 43 537
Shalom Haggiag Italy 17 376 1.5× 260 1.4× 93 1.0× 131 1.7× 77 1.1× 51 710
Domingo Escudero Spain 20 193 0.8× 565 3.0× 131 1.4× 64 0.8× 47 0.7× 41 991
Erna Harboe Norway 19 187 0.7× 175 0.9× 104 1.1× 64 0.8× 48 0.7× 27 1.1k
Eleftherios Stamboulis Greece 16 111 0.4× 375 2.0× 60 0.6× 29 0.4× 93 1.4× 54 766
Alessandro Dinoto Italy 12 229 0.9× 312 1.7× 50 0.5× 86 1.1× 31 0.5× 51 514
A. P. Batocchi Italy 16 166 0.7× 460 2.5× 109 1.1× 52 0.7× 47 0.7× 24 792

Countries citing papers authored by Falk Steffen

Since Specialization
Citations

This map shows the geographic impact of Falk Steffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Falk Steffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Falk Steffen more than expected).

Fields of papers citing papers by Falk Steffen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Falk Steffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Falk Steffen. The network helps show where Falk Steffen may publish in the future.

Co-authorship network of co-authors of Falk Steffen

This figure shows the co-authorship network connecting the top 25 collaborators of Falk Steffen. A scholar is included among the top collaborators of Falk Steffen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Falk Steffen. Falk Steffen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pape, Katrin, Falk Steffen, Sinah Engel, et al.. (2025). Role of CD5 signalling for pro-inflammatory Th17 response in multiple sclerosis. Brain. 149(1). 123–133.
2.
Maiworm, Michelle, Martin Schaller, Jan Hendrik Schäfer, et al.. (2025). BDNF levels in serum and CSF are associated with clinicoradiological characteristics of aggressive disease in MS patients. Journal of Neurology. 272(2). 147–147. 2 indexed citations
3.
Fleischer, Vinzenz, Muthuraman Muthuraman, Falk Steffen, et al.. (2025). Biomarker combinations from different modalities predict early disability accumulation in multiple sclerosis. Frontiers in Immunology. 16. 1532660–1532660. 1 indexed citations
4.
Goereci, Yasemin, Finja Schweitzer, Carsten Finke, et al.. (2024). Cognitive decline in post-COVID-19 syndrome does not correspond with persisting neuronal or astrocytic damage. Scientific Reports. 14(1). 5326–5326. 5 indexed citations
5.
Heidecke, Harald, M. Schott, Falk Steffen, et al.. (2024). Clinical and Diagnostic Features of Post-Acute COVID-19 Vaccination Syndrome (PACVS). Vaccines. 12(7). 790–790. 7 indexed citations
6.
Schaller, Martin, Michelle Maiworm, Jan Hendrik Schäfer, et al.. (2024). Matching proposed clinical and MRI criteria of aggressive multiple sclerosis to serum and cerebrospinal fluid markers of neuroaxonal and glial injury. Journal of Neurology. 271(6). 3512–3526. 7 indexed citations
7.
Maiworm, Michelle, Martin Schaller, Jan Hendrik Schäfer, et al.. (2024). Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis. Multiple Sclerosis and Related Disorders. 87. 105644–105644. 9 indexed citations
8.
Bitar, Lynn, Sonja Gröschel, Falk Steffen, et al.. (2023). Strict blood pressure control following thrombectomy is associated with neuronal injury and poor functional outcome. Annals of Clinical and Translational Neurology. 10(12). 2255–2265.
9.
Engel, Sinah, Erik Ellwardt, Timo Uphaus, et al.. (2023). Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension. Fluids and Barriers of the CNS. 20(1). 3–3. 7 indexed citations
10.
Schaller, Martin, Katharina J. Wenger, Christoph Mayer, et al.. (2023). Relevance of dedicated multiple sclerosis serum biomarkers in predicting contrast enhancement with gadolinium: Results from the REDUCE‐GAD trial. European Journal of Neurology. 30(8). 2393–2400. 6 indexed citations
11.
Yalachkov, Yavor, Michelle Maiworm, Martin Schaller, et al.. (2023). Serum and cerebrospinal fluid BDNF concentrations are associated with neurological and cognitive improvement in multiple sclerosis: A pilot study. Multiple Sclerosis and Related Disorders. 71. 104567–104567. 7 indexed citations
12.
Wenger, Katharina J., Maya Hoelter, Yavor Yalachkov, et al.. (2023). Serum neurofilament light chain is more strongly associated with T2 lesion volume than with number of T2 lesions in patients with multiple sclerosis. European Journal of Radiology. 166. 111019–111019. 5 indexed citations
13.
Steffen, Falk, et al.. (2023). Impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. Med. 4(6). 361–372.e3. 26 indexed citations
14.
Yalachkov, Yavor, Martin Schaller, Jan Hendrik Schäfer, et al.. (2022). Brain-derived neurotrophic factor and neurofilament light chain in cerebrospinal fluid are inversely correlated with cognition in Multiple Sclerosis at the time of diagnosis. Multiple Sclerosis and Related Disorders. 63. 103822–103822. 12 indexed citations
15.
Masanneck, Lars, Leoni Rolfes, Alice Willison, et al.. (2022). Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapies. Multiple Sclerosis and Related Disorders. 63. 103927–103927. 17 indexed citations
16.
Adler, Christoph, Oezguer A. Onur, Simon Braumann, et al.. (2021). Absolute serum neurofilament light chain levels and its early kinetics predict brain injury after out-of-hospital cardiac arrest. Journal of Neurology. 269(3). 1530–1537. 13 indexed citations
17.
Uphaus, Timo, Falk Steffen, Muthuraman Muthuraman, et al.. (2021). NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study. EBioMedicine. 72. 103590–103590. 37 indexed citations
18.
Rébillard, Rose‐Marie, Victoria Mamane, Audrey Daigneault, et al.. (2020). Increased frequency of proinflammatory CD4 T cells and pathological levels of serum neurofilament light chain in adult drug‐resistant epilepsy. Epilepsia. 62(1). 176–189. 41 indexed citations
19.
Uphaus, Timo, et al.. (2020). Stroke Care Within the COVID-19 Pandemic—Increasing Awareness of Transient and Mild Stroke Symptoms Needed. Frontiers in Neurology. 11. 581394–581394. 10 indexed citations
20.
Birkner, Katharina, Julia A. Loos, René Gollan, et al.. (2019). Neuronal ICAM-5 Plays a Neuroprotective Role in Progressive Neurodegeneration. Frontiers in Neurology. 10. 205–205. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timo Uphaus Breakdown of academic impact, for papers by Benjamin Berger Breakdown of academic impact, for papers by Jonas Graf Breakdown of academic impact, for papers by Arianna Sartori Breakdown of academic impact, for papers by Shalom Haggiag Breakdown of academic impact, for papers by Domingo Escudero Breakdown of academic impact, for papers by Erna Harboe Breakdown of academic impact, for papers by Eleftherios Stamboulis Breakdown of academic impact, for papers by Alessandro Dinoto Breakdown of academic impact, for papers by A. P. Batocchi
Rankless by CCL
2026